Potential Management of Circulating Tumor DNA as a Biomarker in Triple-Negative Breast Cancer

As a specific subtype of breast cancer, Triple-negative breast cancer (TNBC) is associated with worse prognosis and higher tumor aggressiveness than HER2-amplified or hormone receptor positive breast cancers. Circulating tumor DNA (ctDNA), as a non-invasive “liquid biopsy”, is an emerging original b...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Mao, Chang, Chunxiao, Pei, Yanqing, Guan, Yin, Chang, Jin, Li, HuiHui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299380/
https://www.ncbi.nlm.nih.gov/pubmed/30588246
http://dx.doi.org/10.7150/jca.28458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299380/
https://www.ncbi.nlm.nih.gov/pubmed/30588246
http://dx.doi.org/10.7150/jca.28458

Ejemplares similares